PortfoliosLab logoPortfoliosLab logo
PROK vs. ANGPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PROK vs. ANGPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProKidney Corp. (PROK) and Anglo American Platinum ADR (ANGPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PROK achieves a -18.75% return, which is significantly lower than ANGPY's -11.75% return.


PROK

1D
-0.55%
1M
4.00%
YTD
-18.75%
6M
-26.02%
1Y
175.72%
3Y*
-43.42%
5Y*
10Y*

ANGPY

1D
-5.61%
1M
-7.72%
YTD
-11.75%
6M
-13.78%
1Y
81.32%
3Y*
20.94%
5Y*
-1.14%
10Y*
17.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PROK vs. ANGPY - Yearly Performance Comparison


2026 (YTD)2025202420232022
PROK
ProKidney Corp.
-18.75%32.54%-5.06%-74.05%-27.02%
ANGPY
Anglo American Platinum ADR
-11.75%202.15%-40.10%-34.38%5.27%

Correlation

The correlation between PROK and ANGPY is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Jul 12, 2022

0.15

Fundamentals

Market Cap

PROK:

$258.30B

ANGPY:

$18.92B

EPS

PROK:

-$0.00

ANGPY:

ZAR 13.76

PS Ratio

PROK:

72.84K

ANGPY:

1.40

PB Ratio

PROK:

981.76

ANGPY:

3.15

Total Revenue (TTM)

PROK:

$889.00K

ANGPY:

ZAR 221.81B

Gross Profit (TTM)

PROK:

-$2.18M

ANGPY:

ZAR 45.66B

EBITDA (TTM)

PROK:

-$112.46M

ANGPY:

ZAR 50.68B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PROK vs. ANGPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PROK
PROK Risk / Return Rank: 8080
Overall Rank
PROK Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
PROK Sortino Ratio Rank: 9999
Sortino Ratio Rank
PROK Omega Ratio Rank: 9898
Omega Ratio Rank
PROK Calmar Ratio Rank: 8080
Calmar Ratio Rank
PROK Martin Ratio Rank: 6969
Martin Ratio Rank

ANGPY
ANGPY Risk / Return Rank: 7474
Overall Rank
ANGPY Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
ANGPY Sortino Ratio Rank: 7171
Sortino Ratio Rank
ANGPY Omega Ratio Rank: 7070
Omega Ratio Rank
ANGPY Calmar Ratio Rank: 7575
Calmar Ratio Rank
ANGPY Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PROK vs. ANGPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProKidney Corp. (PROK) and Anglo American Platinum ADR (ANGPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


PROKANGPYDifference
Sharpe ratioReturn per unit of total volatility

-0.85

Sortino ratioReturn per unit of downside risk

+5.78

Omega ratioGain probability vs. loss probability

1.86

1.22

+0.64

Calmar ratioReturn relative to maximum drawdown

2.52

1.99

+0.53

Martin ratioReturn relative to average drawdown

3.25

4.77

-1.52

PROK vs. ANGPY - Sharpe Ratio Comparison

The current PROK Sharpe Ratio is 0.34, which is lower than the ANGPY Sharpe Ratio of 1.19. The chart below compares the historical Sharpe Ratios of PROK and ANGPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

PROK vs. ANGPY - Drawdown Comparison

The maximum PROK drawdown since its inception was -96.29%, which is greater than ANGPY's maximum drawdown of -78.47%. Use the drawdown chart below to compare losses from any high point for PROK and ANGPY.


Loading charts...

Drawdown Indicators


PROKANGPYDifference

Max Drawdown

Largest peak-to-trough decline

-96.29%

-78.47%

-17.82%

Max Drawdown (1Y)

Largest decline over 1 year

-70.08%

-40.99%

-29.09%

Max Drawdown (3Y)

Largest decline over 3 years

-96.09%

-42.25%

-53.84%

Max Drawdown (5Y)

Largest decline over 5 years

-78.47%

Max Drawdown (10Y)

Largest decline over 10 years

-78.47%

Current Drawdown

Current decline from peak

-86.79%

-41.32%

-45.47%

Average Drawdown

Average peak-to-trough decline

-65.34%

-35.16%

-30.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

54.32%

17.11%

+37.21%

Volatility

PROK vs. ANGPY - Volatility Comparison

The current volatility for ProKidney Corp. (PROK) is 17.44%, while Anglo American Platinum ADR (ANGPY) has a volatility of 23.73%. This indicates that PROK experiences smaller price fluctuations and is considered to be less risky than ANGPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PROKANGPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

17.44%

23.73%

-6.29%

Volatility (6M)

Calculated over the trailing 6-month period

48.67%

56.24%

-7.57%

Volatility (1Y)

Calculated over the trailing 1-year period

525.13%

68.97%

+456.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

283.05%

58.91%

+224.14%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

283.05%

57.16%

+225.89%

Dividends

PROK vs. ANGPY - Dividend Comparison

PROK has not paid dividends to shareholders, while ANGPY's dividend yield for the trailing twelve months is around 3.65%.


PositionTTM20252024202320222021202020192018
ANGPY
Anglo American Platinum ADR
3.65%3.87%3.40%4.85%15.62%10.20%2.91%0.99%1.11%
PROK
ProKidney Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

PROK vs. ANGPY - Financials Comparison

This section allows you to compare key financial metrics between ProKidney Corp. and Anglo American Platinum ADR. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
226.00K
70.49B
(PROK) Total Revenue
(ANGPY) Total Revenue
Please note, different currencies. PROK values in USD, ANGPY values in ZAR

Frequently Asked Questions


PROK and ANGPY have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ANGPY has higher volatility (23.73%) compared to PROK (17.44%). In terms of maximum drawdown, PROK dropped -96.29% vs ANGPY's -78.47%.

ANGPY currently has the higher Sharpe Ratio (1.19 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PROK and ANGPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer